Zoetis Inc. (BMV:ZTS)

Market Cap	964.05B -37.3%
Revenue (ttm)	172.36B +2.7%
Net Income	48.63B +9.1%
EPS	108.89 +11.6%
Shares Out	n/a
PE Ratio	19.83
Forward PE	19.37
Dividend	37.84 (1.71%)
Ex-Dividend Date	Jan 20, 2026

Volume	n/a
Average Volume	992
Open	2,214.88
Previous Close	2,214.88
Day's Range	2,214.88 - 2,214.88
52-Week Range	2,108.00 - 3,612.55
Beta	n/a
RSI	48.91
Earnings Date	Feb 13, 2026

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph...

• Industry: Pharmaceutical Preparations
• Founded: 1950
• Employees: 13,800
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: ZTS

Financial Performance

In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.

Financial numbers in USD